NCT02222181 Impact of Pharmacotherapy Management in Patients With Alzheimer's Disease Status COMPLETED Phase NA
NCT02221947 Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease Status TERMINATED Phase PHASE1/PHASE2
NCT02220738 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors Status TERMINATED Phase PHASE1
NCT02210286 Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia Status COMPLETED Phase NA
NCT02198586 Apoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years Old Status COMPLETED Phase N/A
NCT02185053 A Phase II Study of CPC-201 to Treat Alzheimer's Disease Type Dementia Status COMPLETED Phase PHASE2
NCT02176629 Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease Status COMPLETED Phase NA
NCT02167256 A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT02166827 Effects of a NeuroAD System, for the Treatment of Alzheimer Disease Status TERMINATED Phase NA
NCT02162264 Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice Status COMPLETED Phase N/A
NCT02158910 A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients Status COMPLETED Phase N/A
NCT02155946 Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment Status COMPLETED Phase NA
NCT02137460 Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer's Disease Status COMPLETED Phase N/A
NCT02130661 Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers Status WITHDRAWN Phase PHASE1
NCT02129348 Treatment of Psychosis and Agitation in Alzheimer's Disease Status COMPLETED Phase PHASE2